Trade Mednax - MD CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.10 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Pediatrix Medical Group Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 12.52 |
Open* | 12.42 |
1-Year Change* | -29.31% |
Day's Range* | 12.33 - 12.48 |
52 wk Range | 12.59-19.63 |
Average Volume (10 days) | 480.09K |
Average Volume (3 months) | 9.10M |
Market Cap | 1.09B |
P/E Ratio | 11.20 |
Shares Outstanding | 83.94M |
Revenue | 2.00B |
EPS | 1.16 |
Dividend (Yield %) | N/A |
Beta | 1.72 |
Next Earnings Date | Nov 1, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 22, 2023 | 12.33 | -0.14 | -1.12% | 12.47 | 12.58 | 12.32 |
Sep 21, 2023 | 12.52 | 0.07 | 0.56% | 12.45 | 12.69 | 12.36 |
Sep 20, 2023 | 12.55 | 0.03 | 0.24% | 12.52 | 12.79 | 12.48 |
Sep 19, 2023 | 12.56 | -0.08 | -0.63% | 12.64 | 12.81 | 12.51 |
Sep 18, 2023 | 12.75 | 0.21 | 1.67% | 12.54 | 12.83 | 12.54 |
Sep 15, 2023 | 12.59 | 0.14 | 1.12% | 12.45 | 12.77 | 12.27 |
Sep 14, 2023 | 12.47 | -0.02 | -0.16% | 12.49 | 12.72 | 12.40 |
Sep 13, 2023 | 12.47 | 0.05 | 0.40% | 12.42 | 12.63 | 12.37 |
Sep 12, 2023 | 12.57 | -0.01 | -0.08% | 12.58 | 12.83 | 12.47 |
Sep 11, 2023 | 12.68 | -0.01 | -0.08% | 12.69 | 12.82 | 12.54 |
Sep 8, 2023 | 12.69 | -0.13 | -1.01% | 12.82 | 12.86 | 12.60 |
Sep 7, 2023 | 12.90 | 0.03 | 0.23% | 12.87 | 13.28 | 12.73 |
Sep 6, 2023 | 13.00 | 0.40 | 3.17% | 12.60 | 13.00 | 12.56 |
Sep 5, 2023 | 12.60 | -1.00 | -7.35% | 13.60 | 13.60 | 12.53 |
Sep 1, 2023 | 13.94 | -0.10 | -0.71% | 14.04 | 14.26 | 13.92 |
Aug 31, 2023 | 14.09 | -0.13 | -0.91% | 14.22 | 14.40 | 13.99 |
Aug 30, 2023 | 14.30 | 0.44 | 3.17% | 13.86 | 14.42 | 13.83 |
Aug 29, 2023 | 14.03 | 0.05 | 0.36% | 13.98 | 14.18 | 13.89 |
Aug 28, 2023 | 14.03 | 0.01 | 0.07% | 14.02 | 14.18 | 13.85 |
Aug 25, 2023 | 14.04 | 0.02 | 0.14% | 14.02 | 14.21 | 13.89 |
Mednax Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, November 1, 2023 | ||
Time (UTC) 12:30 | Country US
| Event Q3 2023 Pediatrix Medical Group Inc Earnings Release Q3 2023 Pediatrix Medical Group Inc Earnings ReleaseForecast -Previous - |
Thursday, February 15, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Q4 2023 Pediatrix Medical Group Inc Earnings Release Q4 2023 Pediatrix Medical Group Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 1972.02 | 1911.19 | 1733.95 | 1779.76 | 1723.11 |
Revenue | 1972.02 | 1911.19 | 1733.95 | 1779.76 | 1723.11 |
Total Operating Expense | 1856.35 | 1722.81 | 1635.82 | 1608 | 1474.72 |
Selling/General/Admin. Expenses, Total | 1614.72 | 1560.83 | 1442.89 | 1425.27 | 1357.89 |
Depreciation / Amortization | 35.636 | 32.147 | 28.441 | 25.931 | 24.355 |
Other Operating Expenses, Total | 121.669 | 100.472 | 90.69 | 95.911 | 92.475 |
Operating Income | 115.672 | 188.386 | 98.132 | 171.756 | 248.388 |
Interest Income (Expense), Net Non-Operating | -34.302 | -53.158 | -90.984 | -112.972 | -82.18 |
Net Income Before Taxes | 81.37 | 135.228 | 7.148 | 58.784 | 166.208 |
Net Income After Taxes | 62.564 | 107.987 | -9.58 | 42.208 | 121.514 |
Minority Interest | 0.004 | 0.027 | |||
Net Income Before Extra. Items | 62.568 | 108.014 | -9.58 | 42.208 | 121.514 |
Net Income | 66.335 | 130.964 | -796.488 | -1497.7 | 268.629 |
Income Available to Common Excl. Extra. Items | 62.568 | 108.014 | -9.58 | 42.208 | 121.514 |
Income Available to Common Incl. Extra. Items | 66.335 | 130.964 | -796.488 | -1497.7 | 268.629 |
Diluted Net Income | 66.335 | 130.964 | -796.488 | -1497.7 | 268.629 |
Diluted Weighted Average Shares | 84.121 | 84.832 | 83.395 | 83.495 | 91.606 |
Diluted EPS Excluding Extraordinary Items | 0.74379 | 1.27327 | -0.11487 | 0.50552 | 1.32649 |
Diluted Normalized EPS | 1.51456 | 1.54957 | 0.46035 | 1.02914 | 1.32649 |
Unusual Expense (Income) | 84.328 | 29.352 | 73.801 | 60.89 | 0 |
Total Extraordinary Items | 3.767 | 22.95 | -786.908 | -1539.91 | 147.115 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 500.577 | 491.008 | 513.844 | 489.915 | 486.033 |
Revenue | 500.577 | 491.008 | 513.844 | 489.915 | 486.033 |
Total Operating Expense | 452.079 | 460.967 | 477.806 | 442.528 | 435.878 |
Selling/General/Admin. Expenses, Total | 412.045 | 421.294 | 417.614 | 400.738 | 391.922 |
Depreciation / Amortization | 8.945 | 8.953 | 9.136 | 8.956 | 8.775 |
Unusual Expense (Income) | 0 | 0 | 19.576 | 0.977 | 5.338 |
Other Operating Expenses, Total | 31.089 | 30.72 | 31.48 | 31.857 | 29.843 |
Operating Income | 48.498 | 30.041 | 36.038 | 47.387 | 50.155 |
Interest Income (Expense), Net Non-Operating | -9.551 | -9.329 | -8.214 | -8.528 | -7.122 |
Net Income Before Taxes | 38.947 | 20.712 | 27.824 | 38.859 | 43.033 |
Net Income After Taxes | 28.282 | 14.206 | 24 | 28.808 | 30.701 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Net Income Before Extra. Items | 28.282 | 14.206 | 24 | 28.808 | 30.701 |
Total Extraordinary Items | 0 | 0 | 5.659 | 1.92 | -3.565 |
Net Income | 28.282 | 14.206 | 29.659 | 30.728 | 27.136 |
Income Available to Common Excl. Extra. Items | 28.282 | 14.206 | 24 | 28.808 | 30.701 |
Income Available to Common Incl. Extra. Items | 28.282 | 14.206 | 29.659 | 30.728 | 27.136 |
Diluted Net Income | 28.282 | 14.206 | 29.659 | 30.728 | 27.136 |
Diluted Weighted Average Shares | 82.664 | 82.318 | 82.021 | 82.776 | 85.619 |
Diluted EPS Excluding Extraordinary Items | 0.34213 | 0.17257 | 0.29261 | 0.34802 | 0.35858 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | 0.34213 | 0.17257 | 0.49848 | 0.35677 | 0.40306 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 427.989 | 840.564 | 1549.35 | 731.507 | 659.977 |
Cash and Short Term Investments | 103.063 | 487.106 | 1228.71 | 187.277 | 47.414 |
Cash & Equivalents | 9.824 | 387.391 | 1123.84 | 112.767 | 25.491 |
Short Term Investments | 93.239 | 99.715 | 104.87 | 74.51 | 21.923 |
Total Receivables, Net | 296.787 | 316.024 | 241.931 | 498.869 | 506.723 |
Accounts Receivable - Trade, Net | 296.787 | 301.775 | 241.931 | 498.869 | 506.723 |
Prepaid Expenses | 14.878 | 18.538 | 16.898 | 21.919 | 17.123 |
Other Current Assets, Total | 13.261 | 18.896 | 61.806 | 23.442 | 88.717 |
Total Assets | 2347.89 | 2722.55 | 3347.95 | 4145.9 | 5937.48 |
Property/Plant/Equipment, Total - Net | 140.214 | 135.615 | 132.163 | 177.316 | 90.434 |
Property/Plant/Equipment, Total - Gross | 312.432 | 300.303 | 292.606 | 379.418 | 0 |
Accumulated Depreciation, Total | -172.218 | -164.688 | -160.443 | -202.102 | |
Goodwill, Net | 1532.09 | 1505.43 | 1477.97 | 2710.29 | 4061.44 |
Intangibles, Net | 18.491 | 21.565 | 26.642 | 274.407 | 313.165 |
Long Term Investments | 0 | 69.699 | |||
Other Long Term Assets, Total | 229.101 | 219.372 | 161.827 | 252.379 | 742.767 |
Total Current Liabilities | 426.983 | 427.366 | 444.335 | 541.818 | 502.762 |
Accounts Payable | 31.857 | 36.645 | 59.771 | 39.61 | 31.059 |
Accrued Expenses | 363.957 | 377.157 | 382.319 | 495.573 | 417.508 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 14.898 | 2.49 | 2.219 | 0.13 | 0.253 |
Other Current Liabilities, Total | 16.271 | 11.074 | 0.026 | 6.505 | 53.942 |
Total Liabilities | 1456.26 | 1826.06 | 2600.46 | 2646.91 | 2849.6 |
Total Long Term Debt | 636.381 | 1002.26 | 1742.59 | 1730.3 | 1974.28 |
Long Term Debt | 627.651 | 990.57 | 1733.69 | 1730.24 | 1974.28 |
Deferred Income Tax | 33.638 | 41.409 | 61.746 | 57.995 | 95.581 |
Minority Interest | 0 | 0.205 | 0.232 | ||
Other Liabilities, Total | 359.253 | 354.821 | 351.564 | 316.797 | 276.973 |
Total Equity | 891.632 | 896.487 | 747.485 | 1499 | 3087.88 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.829 | 0.864 | 0.856 | 0.842 | 0.878 |
Additional Paid-In Capital | 983.601 | 1049.7 | 1029.45 | 987.942 | 992.647 |
Retained Earnings (Accumulated Deficit) | -89.063 | -155.39 | -286.354 | 510.212 | 2094.36 |
Total Liabilities & Shareholders’ Equity | 2347.89 | 2722.55 | 3347.95 | 4145.9 | 5937.48 |
Total Common Shares Outstanding | 82.947 | 86.423 | 85.593 | 84.248 | 87.82 |
Other Equity, Total | -3.735 | 1.317 | 3.53 | 0 | |
Capital Lease Obligations | 8.73 | 11.688 | 8.899 | 0.058 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 408.592 | 427.989 | 423.707 | 459.301 | 439.777 |
Cash and Short Term Investments | 102.833 | 103.063 | 100.064 | 107.474 | 96.755 |
Cash & Equivalents | 6.124 | 9.824 | 8.668 | 14.088 | 7.179 |
Short Term Investments | 96.709 | 93.239 | 91.396 | 93.386 | 89.576 |
Total Receivables, Net | 278.739 | 296.787 | 304.08 | 328.73 | 317.619 |
Accounts Receivable - Trade, Net | 278.739 | 296.787 | 294.351 | 307.201 | 317.619 |
Prepaid Expenses | 14.951 | 14.878 | 9.664 | 14.24 | 16.323 |
Other Current Assets, Total | 12.069 | 13.261 | 9.899 | 8.857 | 9.08 |
Total Assets | 2320.05 | 2347.89 | 2331.96 | 2369.62 | 2340.98 |
Property/Plant/Equipment, Total - Net | 139.721 | 140.214 | 141.002 | 139.654 | 138.513 |
Goodwill, Net | 1532.09 | 1532.09 | 1532.09 | 1532.09 | 1528.69 |
Intangibles, Net | 17.487 | 18.491 | 19.534 | 20.965 | 21.05 |
Other Long Term Assets, Total | 222.159 | 229.101 | 215.622 | 217.604 | 212.942 |
Total Current Liabilities | 284.218 | 426.983 | 351.694 | 329.415 | 269.727 |
Accounts Payable | 35.333 | 31.857 | 27.136 | 30.234 | 30.315 |
Accrued Expenses | 212.4 | 363.957 | 301.978 | 277.849 | 222.659 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 14.914 | 14.898 | 14.919 | 14.922 | 2.404 |
Total Liabilities | 1410.28 | 1456.26 | 1473.29 | 1524.19 | 1463.9 |
Total Long Term Debt | 742.814 | 636.381 | 731.004 | 793.254 | 804.93 |
Long Term Debt | 742.814 | 636.381 | 731.004 | 793.254 | 804.93 |
Deferred Income Tax | 32.703 | 33.638 | 39.904 | 43.08 | 39.301 |
Minority Interest | 0 | 0 | 0 | 0 | |
Other Liabilities, Total | 350.545 | 359.253 | 350.688 | 358.437 | 349.942 |
Total Equity | 909.771 | 891.632 | 858.667 | 845.43 | 877.076 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
Common Stock | 0.836 | 0.829 | 0.83 | 0.841 | 0.872 |
Additional Paid-In Capital | 986.923 | 983.601 | 980.659 | 996.624 | 1054.14 |
Retained Earnings (Accumulated Deficit) | -74.857 | -89.063 | -118.722 | -149.45 | -176.586 |
Other Equity, Total | -3.131 | -3.735 | -4.1 | -2.585 | -1.351 |
Total Liabilities & Shareholders’ Equity | 2320.05 | 2347.89 | 2331.96 | 2369.62 | 2340.98 |
Total Common Shares Outstanding | 83.634 | 82.947 | 83.006 | 84.06 | 87.184 |
Other Current Liabilities, Total | 21.571 | 16.271 | 7.661 | 6.41 | 14.349 |
Capital Lease Obligations |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 66.335 | 130.964 | -796.488 | -1497.7 | 268.629 |
Cash From Operating Activities | 166.941 | 76.737 | 204.62 | 357.711 | 313.708 |
Cash From Operating Activities | 35.636 | 32.147 | 28.441 | 25.931 | 24.355 |
Deferred Taxes | -22.771 | -31.239 | 36.292 | -55.715 | -35.894 |
Non-Cash Items | 55.914 | -31.768 | 883.647 | 1869.17 | 146.847 |
Cash Taxes Paid | 26.908 | 54.728 | -27.775 | 86.268 | 185.416 |
Cash Interest Paid | 116.235 | 86.537 | 110.488 | 95.444 | 82.54 |
Changes in Working Capital | 31.827 | -23.367 | 52.728 | 16.032 | -90.229 |
Cash From Investing Activities | -56.954 | -53.073 | 815.511 | 102.455 | -142.769 |
Capital Expenditures | -29.708 | -32.249 | -28.788 | -19.269 | -17.12 |
Other Investing Cash Flow Items, Total | -27.246 | -20.824 | 844.299 | 121.724 | -125.649 |
Cash From Financing Activities | -487.554 | -760.116 | -4.158 | -393.07 | -170.61 |
Financing Cash Flow Items | 0.732 | 0.407 | -1.513 | -19.548 | -13.708 |
Issuance (Retirement) of Stock, Net | -83.115 | 2.134 | -1.484 | -134.022 | -285.902 |
Issuance (Retirement) of Debt, Net | -405.171 | -762.657 | -1.161 | -239.5 | 129 |
Net Change in Cash | -377.567 | -736.452 | 1015.97 | 67.096 | 0.329 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 14.206 | 66.335 | 36.676 | 5.948 | -21.188 |
Cash From Operating Activities | -100.917 | 166.941 | 68.255 | -15.075 | -97.482 |
Cash From Operating Activities | 8.953 | 35.636 | 26.5 | 17.544 | 8.769 |
Deferred Taxes | 2.008 | -22.771 | -8.702 | -1.894 | 2.389 |
Non-Cash Items | 2.738 | 55.914 | 59.002 | 62.138 | 54.119 |
Changes in Working Capital | -128.822 | 31.827 | -45.221 | -98.811 | -141.571 |
Cash From Investing Activities | -11.35 | -56.954 | -45.713 | -39.625 | -26.273 |
Capital Expenditures | -6.999 | -29.708 | -20.65 | -13.703 | -7.145 |
Other Investing Cash Flow Items, Total | -4.351 | -27.246 | -25.063 | -25.922 | -19.128 |
Cash From Financing Activities | 108.567 | -487.554 | -401.265 | -318.603 | -256.457 |
Financing Cash Flow Items | 2.075 | 0.732 | -8.138 | -8.11 | -7.838 |
Issuance (Retirement) of Stock, Net | 0.32 | -83.115 | -82.821 | -62.726 | 0.008 |
Issuance (Retirement) of Debt, Net | 106.172 | -405.171 | -310.306 | -247.767 | -248.627 |
Net Change in Cash | -3.7 | -377.567 | -378.723 | -373.303 | -380.212 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 14.9956 | 12587606 | -58253 | 2023-06-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 12.2634 | 10294115 | 400379 | 2023-06-30 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 10.1176 | 8492909 | 100605 | 2023-06-30 | LOW |
Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 9.7544 | 8188063 | 51947 | 2023-06-30 | LOW |
EARNEST Partners, LLC | Investment Advisor/Hedge Fund | 6.3336 | 5316528 | -1240718 | 2023-06-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 4.8592 | 4078871 | 217701 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.931 | 3299784 | -118151 | 2023-06-30 | LOW |
Lazard Fund Managers (Ireland) Limited | Investment Advisor | 2.8811 | 2418438 | 10373 | 2023-04-30 | MED |
Lazard Asset Management Pacific Company | Investment Advisor | 2.8677 | 2407200 | 2407200 | 2023-05-31 | HIGH |
D. E. Shaw & Co., L.P. | Hedge Fund | 2.0599 | 1729149 | 307931 | 2023-06-30 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9434 | 1631360 | 83125 | 2023-06-30 | LOW |
River Road Asset Management, LLC | Investment Advisor/Hedge Fund | 1.8822 | 1579940 | -13570 | 2023-06-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 1.7015 | 1428272 | 39167 | 2023-06-30 | LOW |
Segall Bryant & Hamill, LLC | Investment Advisor/Hedge Fund | 1.699 | 1426207 | 624479 | 2023-06-30 | LOW |
Citadel Advisors LLC | Hedge Fund | 1.047 | 878852 | 108240 | 2023-06-30 | LOW |
Aristotle Capital Boston, LLC | Investment Advisor | 0.9881 | 829413 | 18534 | 2023-06-30 | LOW |
Palisade Capital Management, LLC | Investment Advisor/Hedge Fund | 0.9661 | 810988 | 38708 | 2023-06-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.9027 | 757717 | 45911 | 2023-06-30 | LOW |
Medel (Roger J M.D.) | Individual Investor | 0.891 | 747930 | 8480 | 2022-05-12 | |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.887 | 744533 | 21358 | 2022-12-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Mednax Company profile
Mednax, Inc. is an American health solutions partner comprised of the nation’s leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The company was founded in 1979, and today, through its affiliated professional corporations, provides services through a network of more than 4,075 physicians located in 50 states and Puerto Rico. In addition to its national physician network, Mednax provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a management services company and a consulting services company. Get all the latest on the Mednax share price at Capital.com.Industry: | Healthcare Facilities & Services (NEC) |
1301 Concord Terrace
SUNRISE
FLORIDA 33323
US
Income Statement
- Annual
- Quarterly
News

EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023
Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally
The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.
13:46, 15 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com